Hayama K - Search Results

1

Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks.

Jain V, Giménez-Arnau A, Hayama K, Reich A, Carr W, Tillinghast J, Dahale S, Lheritier K, Walsh P, Zharkov A, Hugot S, Haemmerle S. Jain V, et al. Among authors: hayama k. J Allergy Clin Immunol. 2024 Feb;153(2):479-486.e4. doi: 10.1016/j.jaci.2023.10.007. Epub 2023 Oct 20. J Allergy Clin Immunol. 2024. PMID: 37866460 Free article.

2

Patients who have anti-FcεRI nonreactive basophils do not represent patients with severe chronic spontaneous urticaria.

Endo T, Toyoshima S, Hayama K, Terui T, Okayama Y. Endo T, et al. Among authors: hayama k. J Allergy Clin Immunol Pract. 2020 Feb;8(2):824-825.e2. doi: 10.1016/j.jaip.2019.11.032. J Allergy Clin Immunol Pract. 2020. PMID: 32037120 No abstract available.

3

Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria.

Maurer M, Berger W, Giménez-Arnau A, Hayama K, Jain V, Reich A, Haemmerle S, Lheritier K, Walsh P, Xia S, Storim J. Maurer M, et al. Among authors: hayama k. J Allergy Clin Immunol. 2022 Dec;150(6):1498-1506.e2. doi: 10.1016/j.jaci.2022.08.027. Epub 2022 Sep 9. J Allergy Clin Immunol. 2022. PMID: 36096203 Free article. Clinical Trial.

4

Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study.

Fukunaga A, Kakei Y, Murakami S, Kan Y, Masuda K, Jinnin M, Washio K, Amano H, Nagano T, Yamamoto A, Otsuka T, Takahagi S, Takenaka M, Ishiguro N, Hayama K, Inomata N, Nakagawa Y, Sugiyama A, Hide M. Fukunaga A, et al. Among authors: hayama k. Front Immunol. 2024 Sep 16;15:1441478. doi: 10.3389/fimmu.2024.1441478. eCollection 2024. Front Immunol. 2024. PMID: 39351222 Free PMC article. Clinical Trial.

5

High IgG Anti-IgE Autoantibodies Prevent Early Omalizumab Response in Chronic Spontaneous Urticaria.

Niwa Y, Hayama K, Toyoshima S, Shimizu K, Tagui M, Ito M, Sakamoto T, Terui T, Fujita H, Okayama Y. Niwa Y, et al. Among authors: hayama k. Allergy. 2024 Dec 6. doi: 10.1111/all.16419. Online ahead of print. Allergy. 2024. PMID: 39641592 No abstract available.

6

Significantly high levels of anti-dsDNA immunoglobulin E in sera and the ability of dsDNA to induce the degranulation of basophils from chronic urticaria patients.

Hatada Y, Kashiwakura J, Hayama K, Fujisawa D, Sasaki-Sakamoto T, Terui T, Ra C, Okayama Y. Hatada Y, et al. Among authors: hayama k. Int Arch Allergy Immunol. 2013;161 Suppl 2:154-8. doi: 10.1159/000350388. Epub 2013 May 29. Int Arch Allergy Immunol. 2013. PMID: 23711867

7

Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria.

Fujisawa D, Kashiwakura J, Kita H, Kikukawa Y, Fujitani Y, Sasaki-Sakamoto T, Kuroda K, Nunomura S, Hayama K, Terui T, Ra C, Okayama Y. Fujisawa D, et al. Among authors: hayama k. J Allergy Clin Immunol. 2014 Sep;134(3):622-633.e9. doi: 10.1016/j.jaci.2014.05.004. Epub 2014 Jun 19. J Allergy Clin Immunol. 2014. PMID: 24954276

8

Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria.

Endo T, Toyoshima S, Hayama K, Tagui M, Niwa Y, Ito M, Terui T, Okayama Y. Endo T, et al. Among authors: hayama k. Asia Pac Allergy. 2020 Apr 10;10(2):e12. doi: 10.5415/apallergy.2020.10.e12. eCollection 2020 Apr. Asia Pac Allergy. 2020. PMID: 32411577 Free PMC article.

9

miR103a-3p in extracellular vesicles from FcεRI-aggregated human mast cells enhances IL-5 production by group 2 innate lymphoid cells.

Toyoshima S, Sakamoto-Sasaki T, Kurosawa Y, Hayama K, Matsuda A, Watanabe Y, Terui T, Gon Y, Matsumoto K, Okayama Y. Toyoshima S, et al. Among authors: hayama k. J Allergy Clin Immunol. 2021 May;147(5):1878-1891. doi: 10.1016/j.jaci.2021.01.002. Epub 2021 Jan 17. J Allergy Clin Immunol. 2021. PMID: 33465368

10

Serum level of hemokinin-1 is significantly lower in patients with chronic spontaneous urticaria than in healthy subjects.

Nishimori N, Toyoshima S, Sasaki-Sakamoto T, Hayama K, Terui T, Okayama Y. Nishimori N, et al. Among authors: hayama k. Allergol Int. 2021 Oct;70(4):480-488. doi: 10.1016/j.alit.2021.05.002. Epub 2021 Jun 3. Allergol Int. 2021. PMID: 34090787 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters